We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-9.48%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$116B
AUM Growth
-$22.1B
Cap. Flow
+$6B
Cap. Flow %
5.18%
Top 10 Hldgs %
17.41%
Holding
4,413
New
281
Increased
1,595
Reduced
1,871
Closed
461

Top Buys

Rank Stock Value
1
FXI icon
iShares China Large-Cap ETF
FXI
+$473M
2
AGN
Allergan plc
AGN
+$384M
3
LIN icon
Linde
LIN
+$332M
4
MCK icon
McKesson
MCK
+$329M
5
AVGO icon
Broadcom
AVGO
+$300M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Healthcare 12.82%
3 Financials 9.51%
4 Consumer Discretionary 7.09%
5 Communication Services 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFP
4201
DELISTED
Resolute Forest Products Inc.
RFP
-10,501
Closed -$45K
SRNE
4202
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-135,979
Closed -$459K
CLVS
4203
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
-50,000
Closed -$521K
PBFX
4204
DELISTED
PBF LOGISTICS LP
PBFX
-10,882
Closed -$220K
RWGV
4205
DELISTED
Direxion Russell 1000 Growth Over Value ETF
RWGV
-40,000
Closed -$2.66M
ENDP
4206
CALL
DELISTED
Endo International plc
ENDP
-1,000,000
Closed -$4.69M
EMWP
4207
DELISTED
Eros Media World PLC
EMWP
-3,227
Closed -$219K
GSV
4208
DELISTED
Gold Standard Ventures Corp.
GSV
-117,500
Closed -$101K
NPTN
4209
DELISTED
NEOPHOTONICS CORP
NPTN
-14,167
Closed -$125K
WBT
4210
DELISTED
Welbilt, Inc.
WBT
-113,393
Closed -$1.77M
SFUN
4211
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
-1,358
Closed -$39K
FRTA
4212
DELISTED
Forterra, Inc
FRTA
-57,724
Closed -$667K
CSLT
4213
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-14,662
Closed -$20K
XLNX
4214
CALL
DELISTED
Xilinx Inc
XLNX
-376,500
Closed -$36.8M
OMP
4215
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
-29,805
Closed -$494K
ODT
4216
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-10,032
Closed -$326K
TGP
4217
DELISTED
Teekay LNG Partners L.P.
TGP
-311,665
Closed -$4.85M
ZIXI
4218
DELISTED
Zix Corporation
ZIXI
-77,515
Closed -$526K
KSU
4219
CALL
DELISTED
Kansas City Southern
KSU
-50,000
Closed -$7.66M
CAI
4220
DELISTED
CAI International, Inc.
CAI
-9,999
Closed -$290K
LORL
4221
DELISTED
Loral Space and Communications, Inc.
LORL
-6,379
Closed -$206K
CLDR
4222
PUT
DELISTED
Cloudera, Inc.
CLDR
-522,500
Closed -$6.08M
ALTA
4223
DELISTED
Altabancorp
ALTA
-8,241
Closed -$248K
SWI
4224
DELISTED
SolarWinds Corporation Common Stock
SWI
-22,769
Closed -$446K
ALXN
4225
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
-7,500
Closed -$811K

Similar funds

Credit Suisse's Q1 2020 Portfolio in Review

As of Q1 2020, Credit Suisse held 4,413 positions worth $116B, down 16% from $138B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse deployed $6B of net new capital in Q1 2020, opening 281 new positions and adding to 1,595 existing holdings. Its largest new stake was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.

  • Credit Suisse's largest Q1 2020 buy was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
  • Credit Suisse added most to iShares China Large-Cap ETF in Q1 2020, an estimated $473M increase.
  • Credit Suisse's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
  • Credit Suisse fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $285M.
  • Credit Suisse's ten largest holdings make up 17% of its $116B portfolio in Q1 2020.
  • Credit Suisse opened 281 new positions and closed 461 in Q1 2020.
  • Credit Suisse's portfolio value fell 16% quarter-over-quarter to $116B.

Based on Credit Suisse's 13F filing for Q1 2020, filed 13 May 2020.